Case Report: Fever of Unknown Origin <br/>—An Unusual Presentation for Diffuse Large B-Cell Lymphoma
- 1 Department of Internal Medicine, East Tennessee State University, Johnson City, TN, USA
- 2 Department of Internal Medicine, East Tennessee State University, Johnson City, TN, USA
- 3 Department of Internal Medicine, East Tennessee State University, Johnson City, TN, USA
- 4 Department of Hematology and Oncology, James Quillen Veterans Affairs, Mountain Home, TN, USA
Abstract
A 61-year-old male initially presented with fever of unknown origin. He had extensive work-up over two years including an infectious diseases panel, autoimmune studies, and Rheumatology and Hematology evaluations. The patient was initially diagnosed with Adult Still’s disease and underwent an out-patient right nodal fine-needle aspiration that was indeterminate. After continued failure of treatment for Adult Still’s disease, the patient had surgical resection of a right axillary lymph node that yielded the diagnosis of diffuse large B-cell lymphoma. Further work-up revealed Epstein-Barr virus positivity, the possible trigger behind his mutation for diffuse large B-cell lymphoma and its uncommon presentation. The patient met criteria for central nervous system prophylaxis and received multiple administrations throughout his therapy. He ultimately expired following recurrence of his disease at its initial site but without central nervous system involvement. We report an uncommon presentation of a patient with diffuse large B-cell lymphoma. This lymphoma can have numerous, vague presentations requiring a broad differential diagnosis and may lead to multiple evaluations prior to an ultimate diagnosis. We will also discuss the need for central nervous system prophylaxis, how this patient is qualified for prophylaxis, and how central nervous system prophylaxis benefits, harms, or does not affect patients with diffuse large B-cell lymphoma.
- Hagop (2016) MD Anderson Manual of Medical Oncology. McGraw-Hill Education, Hong Kong.
- Swerdlow, S.H. (2008) World Health Organization of Tumors of Haematopoeitic and Lymphoid Tissues. IARC Press, Lyon.
- Moller, M.B., Pedersen, N.T. and Christensen, B.E. (2004) Diffuse Large B-Cell Lymphoma: Clinical Implications of Extranodal versus Nodal Presentation—A Population-Based Study of 1575 Cases. British Journal of Haematology, 124, 151. https://doi.org/10.1046/j.1365-2141.2003.04749.x
- Armitage, J.O. and Weisenburger, D.D. (1998) New Approach to Classifying Non-Hodgkin’s Lymphomas: Clinical Features of the Major Histologic Subtypes. Non-Hodgkin’s Lymphoma Classification Project. Journal of Clinical Oncology, 16, 2780. https://doi.org/10.1200/JCO.1998.16.8.2780
- Roschewski, M., Staudt, L.M. and Wilson, W.H. (2014) Diffuse Large B-Cell Lymphoma—Treatment Approaches in the Molecular Era. Nature Reviews. Clinical Oncology, 11, 12-23. https://doi.org/10.1038/nrclinonc.2013.197
- Oh, E.J., Hong, S.W., Jeong, H.J. and Yoon, S.O. (2014) The Diagnostic Approach to Fine-Needle Aspiration of Malignant Lymphoma: Using Cytomorphology and Immunocytochemistry with Cell Transfer Method. Diagnostic Cytopathology, 42, 671-679. https://doi.org/10.1002/dc.23110
- Song, C.G., Huang, J.J., Li, Y.J., Xia, Y., Wang, Y., Bi, X.W., Jiang W.Q., Huang, H.Q., Lin, T.Y. and Li, Z.M. (2015) Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis. PLoS ONE, 29, 7. https://doi.org/10.1371/journal.pone.0133973
- Van Besien, K., Ha, C.S., Murphy, S., McLaughlin, P., Rodriguez, A., Amin, K., Forman, A., Romaguera, J., Hagemeister, F., Bachier, C., Sarris, A., Sobocinski, K.S., Cox, J.D. and Cabanillas, F. (1998) Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults with Intermediate-Grade and Immunoblastic Lymphoma. Blood, 91, 1178.
- Arkenau, H.T., Chong, G., Cunningham, D., Watkins, D., Agarwal, R., Sirohi, B., Trumper, M., Norman, A., Wotherspoon, A. and Horwich, A. (2007) The Role of Intrathecal Chemotherapy Prophylaxis in Patients with Diffuse Large B-Cell Lymphoma. Annals of Oncology, 18, 541-545. https://doi.org/10.1093/annonc/mdl434
- Kridel, R. and Dietrich, P.Y. (2011) Prevention of CNS Relapse in Diffuse Large B-Cell Lymphoma. The Lancet Oncology, 12, 1258-1266.
- Herman, T.S., Hammond N., Jones, S.E., et al. (1979) Involvement of the Central Nervous System by Non-Hodgkin’s Lymphoma: Southwest Oncology Group Experience. Cancer, 43, 390-397. https://doi.org/10.1002/1097-0142(197901)43:1 3.0.CO;2-U